Avricore Health Inc. (TSXV:AVCR)

Avricore Health Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6	6	17	31	16	7
Market Cap Growth	-67.11%	-67.11%	-45.81%	100.33%	135.02%	321.81%
Enterprise Value	5	5	17	30	13	8
Last Close Price	0.06	0.06	0.17	0.32	0.16	0.10
PS Ratio	1.27	1.16	4.86	17.68	127.07	201.03
PB Ratio	3.09	2.83	8.43	15.92	7.10	-9.30
P/TBV Ratio	3.18	2.92	8.63	16.16	7.21	-
P/FCF Ratio	7.38	6.77	-	-	-	-
P/OCF Ratio	6.05	5.55	25.65	-	-	-
EV/Sales Ratio	1.03	1.00	4.76	17.21	109.29	228.81
EV/EBITDA Ratio	7.84	7.60	-	-	-	-
EV/EBIT Ratio	27.58	26.72	-	-	-	-
EV/FCF Ratio	5.99	5.81	-	-	-	-
Debt / Equity Ratio	-	-	0.02	0.02	0.02	-1.40
Asset Turnover	1.98	1.98	1.37	0.73	0.09	0.10
Inventory Turnover	274.33	274.33	-	-	-	-
Quick Ratio	4.72	4.72	1.35	2.32	24.91	0.27
Current Ratio	4.79	4.79	1.46	2.37	25.56	0.38
Return on Equity (ROE)	-33.65%	-33.65%	-35.30%	-39.33%	-230.38%	-
Return on Assets (ROA)	4.62%	4.62%	-14.33%	-16.84%	-65.05%	-202.18%
Return on Capital (ROIC)	5.57%	5.57%	-18.06%	-19.26%	-70.13%	-
Return on Capital Employed (ROCE)	9.10%	9.10%	-	-	-	-
Earnings Yield	-11.01%	-12.01%	-4.14%	-2.62%	-10.95%	-17.68%
FCF Yield	13.55%	14.78%	-2.13%	-5.22%	-8.58%	-18.42%
Buyback Yield / Dilution	-0.76%	-0.76%	-1.74%	-5.67%	-53.20%	-27.82%

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.